In addition, MAC released by CPPM in tumor cells can promote TME remodeling by regulating T-cell subsets, reverse immunosuppressive TME, activate CD3+ CD8+ T cells, and exert efficient antitumor ability [22,23]. This evidence concerns the gene CD8A and neoplasm.